Info

Psychedelics Today

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
RSS Feed Subscribe in Apple Podcasts
Psychedelics Today
2024
October
September
August
July
June
May
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May


Categories

All Episodes
Archives
Categories
Now displaying: December, 2022
Psychedelics Weekly – Psilocybin and Stress Response, the Minnesota Medical Association Endorses Decriminalization, and Scott Wiener Introduces Senate Bill 58 0
Dec 30, 2022

In this episode, Joe and Kyle cover a study where psilocybin improved stress response; The Economist highlighting psychedelic medicine as a main story for 2023; and the Minnesota Medical Association endorsing decriminalization.

www.psychedelicstoday.com

PT379 – Sutton King, MPH – Intergenerational Trauma, Late-Stage Capitalism, and the Urban Indigenous Collective 0
Dec 27, 2022

In this episode, David interviews internationally recognized Indigenous rights activist: Sutton King, MPH. She discusses the challenges Indigenous people continue to face from intergenerational trauma, and their resiliency.

www.psychedelicstoday.com

Psychedelics Weekly – Prop 122 and Data Privacy, Ending the Crack/Cocaine Sentencing Disparity, and the High Cost of Psychedelic Therapy 0
Dec 23, 2022

In this episode, Joe and Kyle discuss concerns over Prop 122 and data privacy, the hopeful end to the sentencing disparity between crack cocaine and powder; and the cost vs. value problem of psychedelic therapy: is it worth it? 

www.psychedelicstoday.com

PT378 – Zach Leary – Course Corrections, Preparation, and High-dose Experiences: "Who Are You Now?" 0
Dec 20, 2022

In this episode, Joe interviews Zach Leary: author, facilitator, trainer, host of the MAPS podcast, and of course, son of psychedelic legend: Timothy Leary. They discuss Ram Dass, Michael Pollan, flotation tanks, and more.

www.psychedelicstoday.com

Psychedelics Weekly – Proposition 122 in Action, The Economics of Psychedelics, and Could States Legalize by 2037? 0
Dec 16, 2022

In this episode, Joe & David discuss the DA dropping a felony drug charge against a Denver mushroom rabbi, the economics of psychedelic-assisted therapies, and the belief that most US states will legalize psychedelics by 2037. 

www.psychedelicstoday.com

PT377 – Andrew Weil, M.D. – Integrative Medicine: Health, Wellness, and Psychedelics 0
Dec 13, 2022

In this episode, Joe interviews New York Times best-selling author, pioneer in the field of integrative medicine, legend in the health and wellness space, and (somewhat surprising to us) psychedelic advocate, Andrew Weil, M.D. 

www.psychedelicstoday.com

Psychedelics Weekly – Genetic Memory, "The Psychedelic Renaissance," and Harm Reduction at Music Festivals 0
Dec 9, 2022

In this episode of Psychedelics Weekly, Joe and David discuss methylation and genetic memory; why the term, “The Psychedelic Renaissance” is problematic; and the importance of harm reduction – especially at music festivals.

www.psychedelicstoday.com

PT376 – Sherry Rais – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits 0
Dec 6, 2022

In this episode, David interviews Sherry Rais: CEO/Co-Founder of Enthea, a benefit plan administrator offering psychedelic-assisted therapy as a benefit to interested employers.

www.psychedelicstoday.com

Psychedelics Weekly – Cannabis as an Adjunct Cancer Treatment & 5-MeO-DMT Reactivations 0
Dec 2, 2022

In this episode, Joe and Alexa discuss our first conference-meets-festival, Convergence; a study looking at the potentiality of 5-MeO-DMT reactivation; and the story of a woman using cannabis as an adjunct treatment for cancer.

www.psychedelicstoday.com

1